ATE382696T1 - Immunoreaktive antigene des hepatitis e viruses - Google Patents
Immunoreaktive antigene des hepatitis e virusesInfo
- Publication number
- ATE382696T1 ATE382696T1 AT94928211T AT94928211T ATE382696T1 AT E382696 T1 ATE382696 T1 AT E382696T1 AT 94928211 T AT94928211 T AT 94928211T AT 94928211 T AT94928211 T AT 94928211T AT E382696 T1 ATE382696 T1 AT E382696T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- virus
- viruse
- molecules
- immunoreactive antigens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM142393 | 1993-09-24 | ||
AUPM2964A AUPM296493A0 (en) | 1993-12-15 | 1993-12-15 | Immunoreactive antigens of hepatitis e virus - II |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE382696T1 true ATE382696T1 (de) | 2008-01-15 |
Family
ID=25644547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94928211T ATE382696T1 (de) | 1993-09-24 | 1994-09-23 | Immunoreaktive antigene des hepatitis e viruses |
Country Status (9)
Country | Link |
---|---|
US (1) | US6514690B1 (de) |
EP (1) | EP0722499B1 (de) |
JP (1) | JPH09503912A (de) |
AT (1) | ATE382696T1 (de) |
AU (1) | AU694139B2 (de) |
CA (1) | CA2170521A1 (de) |
DE (1) | DE69435059D1 (de) |
SG (1) | SG95574A1 (de) |
WO (1) | WO1995008632A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214970B1 (en) * | 1988-06-17 | 2001-04-10 | Genelabs Technologies, Inc. | Hepatitis E virus antigens and uses therefor |
JPH08504096A (ja) | 1992-09-18 | 1996-05-07 | アメリカ合衆国 | E型肝炎パキスタン株の組換えタンパク質ならびに診断法およびワクチンにおけるそれらの利用 |
US6207416B1 (en) | 1992-09-18 | 2001-03-27 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
US6787145B1 (en) | 1992-09-18 | 2004-09-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
EP0722499B1 (de) * | 1993-09-24 | 2008-01-02 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | Immunoreaktive antigene des hepatitis e viruses |
US6054567A (en) * | 1997-04-11 | 2000-04-25 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
US6458562B1 (en) | 1998-04-09 | 2002-10-01 | The United States Of America As Represented By The Secretary Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
CA2283538A1 (en) * | 1999-09-30 | 2001-03-30 | Mun Hon Ng | New hev antigenic peptide and methods |
BRPI0214188B8 (pt) * | 2001-11-08 | 2021-05-25 | Beijing Wantai Biological Pharmacy Entpr Co Ltd | anticorpo ou fragmento do mesmo, molécula de ácido nucléico, uso do anticorpo monoclonal ou fragmento do mesmo, kit de diagnóstico, composição farmacêutica, vetor de expressão recombinante, célula hospedeira transformada com o vetor de expressão recombinante e método para detectar o antígeno do vírus da hepatite e ou o anticorpo contra o vírus da hepatite e em uma amostra |
FR3044312B1 (fr) | 2015-11-30 | 2017-12-08 | Biomerieux Sa | Polypeptides mutes de hev et leur utilisation pour le dosage d'anticorps anti-hev |
WO2018057773A1 (en) * | 2016-09-22 | 2018-03-29 | The Trustees Of Princeton University | Methods and compositions for inhibiting hepatitis e virus |
EP3574000A1 (de) * | 2017-01-30 | 2019-12-04 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Hepatitis-e-virus-orf2-capsid-polypeptide und verwendungen davon |
CN106939034B (zh) * | 2017-03-22 | 2021-03-30 | 中国食品药品检定研究院 | 用于鉴定受试者所感染的hev基因型的方法和试剂盒 |
JP7455108B2 (ja) * | 2018-07-10 | 2024-03-25 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | E型肝炎ウイルスのORF2iタンパク質に対する特異性を有する抗体及び診断目的のためのその使用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6455492B1 (en) * | 1988-06-17 | 2002-09-24 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
US5885768A (en) * | 1988-06-17 | 1999-03-23 | The United States Of America As Represented By The Department Of Health And Human Services | Hepatitis E virus peptide antigen and antibodies |
US5741490A (en) * | 1988-06-17 | 1998-04-21 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
JPH08504096A (ja) * | 1992-09-18 | 1996-05-07 | アメリカ合衆国 | E型肝炎パキスタン株の組換えタンパク質ならびに診断法およびワクチンにおけるそれらの利用 |
EP0722499B1 (de) * | 1993-09-24 | 2008-01-02 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | Immunoreaktive antigene des hepatitis e viruses |
-
1994
- 1994-09-23 EP EP94928211A patent/EP0722499B1/de not_active Expired - Lifetime
- 1994-09-23 AT AT94928211T patent/ATE382696T1/de not_active IP Right Cessation
- 1994-09-23 SG SG9603309A patent/SG95574A1/en unknown
- 1994-09-23 JP JP7509443A patent/JPH09503912A/ja active Pending
- 1994-09-23 WO PCT/AU1994/000572 patent/WO1995008632A1/en active IP Right Grant
- 1994-09-23 AU AU77348/94A patent/AU694139B2/en not_active Ceased
- 1994-09-23 DE DE69435059T patent/DE69435059D1/de not_active Expired - Lifetime
- 1994-09-23 CA CA002170521A patent/CA2170521A1/en not_active Abandoned
-
1998
- 1998-10-14 US US09/172,699 patent/US6514690B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0722499A1 (de) | 1996-07-24 |
AU694139B2 (en) | 1998-07-16 |
AU7734894A (en) | 1995-04-10 |
JPH09503912A (ja) | 1997-04-22 |
SG95574A1 (en) | 2003-04-23 |
EP0722499A4 (de) | 2000-12-27 |
EP0722499B1 (de) | 2008-01-02 |
US6514690B1 (en) | 2003-02-04 |
CA2170521A1 (en) | 1995-03-30 |
DE69435059D1 (de) | 2008-02-14 |
WO1995008632A1 (en) | 1995-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI935808A (fi) | Hepatit-C-virus (HCV) polypeptider | |
ATE382696T1 (de) | Immunoreaktive antigene des hepatitis e viruses | |
DE69029092T2 (de) | Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus | |
DE69232906D1 (de) | Detektion des Hepatis-C Virus. | |
PL343638A1 (en) | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue | |
DE69928064D1 (de) | Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen | |
EP0967223A3 (de) | Hepatitis C Virus Peptidantigene und Verfahren zur Bestimung von Hepatitis C Virus (HCV) | |
WO1995032290A3 (en) | Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof | |
ATE435034T1 (de) | Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist. | |
Dueñas‐Carrera et al. | Immunological evaluation of Escherichia coli‐derived hepatitis C virus second envelope protein (E2) variants | |
GB2299994A (en) | Equine arteritis virus peptides antibodies and their use in a diagnostic test | |
SG145521A1 (en) | Synthetic antigens for the detection of antibodies to hepatitis c virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |